In the literature by Hiromichi et al., the DPP-4 inhibitor vildagliptin reduced T2DM-induced increase in acute mortality after myocardial infarction with the restoration of autophagy [23], demonstrating the potential role of DPP-4 inhibitor in regulating autophagy. Here, DPP4 is linked to myocardial infarction.